Sequencing ALK inhibitors: alectinib in crizotinib-resistant patients, a phase 2 trial by Shaw et al.
about
Sequencing ALK inhibitors: alectinib in crizotinib-resistant patients, a phase 2 trial by Shaw et al.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Sequencing ALK inhibitors: ale ...... a phase 2 trial by Shaw et al.
@en
Sequencing ALK inhibitors: ale ...... a phase 2 trial by Shaw et al.
@nl
type
label
Sequencing ALK inhibitors: ale ...... a phase 2 trial by Shaw et al.
@en
Sequencing ALK inhibitors: ale ...... a phase 2 trial by Shaw et al.
@nl
prefLabel
Sequencing ALK inhibitors: ale ...... a phase 2 trial by Shaw et al.
@en
Sequencing ALK inhibitors: ale ...... a phase 2 trial by Shaw et al.
@nl
P2860
P356
P1476
Sequencing ALK inhibitors: ale ...... a phase 2 trial by Shaw et al
@en
P2093
Benjamin Besse
P2860
P304
P356
10.21037/JTD.2016.11.76
P577
2016-11-01T00:00:00Z